Clinicaltrials.gov indicates that more than half of clinical trials are being conducted outside the United States in developing countries, and that number is expected to grow.
Why the dramatic change in acceptance of global clinical trials?
Lionbridge Life Sciences had an opportunity to hear directly from many respected members of the Drug Information Association (DIA) at their 2014 Annual Meeting in San Diego, California, about the topic of global clinical trials. Complicated regulations in the United States and rising costs were the primary reasons cited as to why pharmaceutical companies look outside the United States to conduct trials.
Results of our DIA pulse poll revealed that efforts need to continue in helping those involved in global trials adapt to — and comply with — the rapid pace of change. Topics surveyed in our poll include:
- Greatest challenges in conducting global clinical trials
- Top emerging markets for studies
- Impact of mobile technologies on clinical research
- Experience with virtual clinical trials
- Key attributes in a language service provider (LSP)
Stay informed on attitudes surrounding global clinical trials by downloading our eBook today
Lionbridge Life Sciences is the Official Welcome Cocktail Sponsor for the 8th annual BioPharma Asia Convention 2015. Learn more
About Lionbridge Life Sciences
Lionbridge Life Sciences offers sophisticated, scalable solutions backed by industry-leading expertise built to overcome the complexities of global communications. Our clinical teams scale programs for trials of all sizes, offering service and support to deliver accurate, consistent translations and the greatest impact for your message across many languages, markets and cultures. Learn more at lifesciences.lionbridge.com